Alps Advisors Inc Viking Therapeutics, Inc. Transaction History

Alps Advisors Inc

$17.2 Billion
Q2 2025

A detailed history of Alps Advisors Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 60,629 shares of VKTX stock, worth $2.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

60,629

Holding current value

$2.3 Million

% of portfolio

0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$19.98 - $29.49 $1.21 Million - $1.79 Million	60,629 New	60,629 $1.61 Million
Q1 2024 May 14, 2024	BUY	$17.4 - $94.5 $132,762 - $721,035	7,630 Added 11.49%	74,007 $6.07 Million
Q4 2023 Feb 14, 2024	SELL	$9.24 - $19.64 $68,634 - $145,885	-7,428 Reduced 10.06%	66,377 $1.24 Million
Q3 2023 Nov 14, 2023	BUY	$10.92 - $16.0 $4,564 - $6,688	418 Added 0.57%	73,805 $817,000
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $321,567 - $537,174	21,669 Added 41.9%	73,387 $1.19 Million
Q1 2023 May 10, 2023	SELL	$8.08 - $17.33 $2,626 - $5,632	-325 Reduced 0.62%	51,718 $861,000
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $141,556 - $489,204	52,043 New	52,043 $489,000
Q2 2022 Aug 11, 2022	SELL	$2.11 - $3.15 $169,939 - $253,701	-80,540 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.0 - $4.88 $29,997 - $48,795	-9,999 Reduced 11.04%	80,540 $242,000
Q4 2021 Feb 09, 2022	SELL	$4.6 - $6.72 $24,361 - $35,589	-5,296 Reduced 5.53%	90,539 $416,000
Q3 2021 Nov 15, 2021	SELL	$5.58 - $7.04 $39,227 - $49,491	-7,030 Reduced 6.83%	95,835 $602,000
Q2 2021 Aug 11, 2021	SELL	$5.19 - $6.73 $151,096 - $195,930	-29,113 Reduced 22.06%	102,865 $616,000
Q1 2021 May 07, 2021	BUY	$5.74 - $9.67 $2,692 - $4,535	469 Added 0.36%	131,978 $835,000
Q4 2020 Feb 03, 2021	BUY	$5.3 - $6.71 $205,210 - $259,804	38,719 Added 41.73%	131,509 $740,000
Q3 2020 Nov 04, 2020	SELL	$5.73 - $8.11 $35,738 - $50,582	-6,237 Reduced 6.3%	92,790 $540,000
Q2 2020 Aug 05, 2020	SELL	$4.35 - $8.08 $140,726 - $261,396	-32,351 Reduced 24.62%	99,027 $714,000
Q1 2020 May 06, 2020	SELL	$3.45 - $7.95 $52,860 - $121,809	-15,322 Reduced 10.44%	131,378 $615,000
Q4 2019 Feb 07, 2020	BUY	$6.38 - $8.73 $17,104 - $23,405	2,681 Added 1.86%	146,700 $1.18 Million
Q3 2019 Nov 04, 2019	SELL	$6.55 - $8.6 $44,481 - $58,402	-6,791 Reduced 4.5%	144,019 $991,000
Q2 2019 Aug 07, 2019	SELL	$7.67 - $10.63 $167,152 - $231,659	-21,793 Reduced 12.63%	150,810 $1.25 Million
Q1 2019 May 01, 2019	BUY	$7.58 - $9.94 $56,531 - $74,132	7,458 Added 4.52%	172,603 $1.72 Million
Q4 2018 Feb 04, 2019	BUY	$7.16 - $16.21 $1.18 Million - $2.68 Million	165,145 New	165,145 $1.26 Million

Others Institutions Holding VKTX

# of Institutions

451

Shares Held

67.9M

Call Options Held

7.72M

Put Options Held

3.25M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.91B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Viking Therapeutics, Inc. Transaction History